Investigation and Analysis on the Involvement of Hospital Pharmacists in Chronic Disease Management in China
SUN Xue-lin1, QIAN Dong-fang2, ZHANG Zi-xuan2, HU Xin1, JIN Peng-fei1*
1. Department of Pharmacy, Beijing Hospital National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application(Beijing Hospital), Beijing 100730, China; 2. Beijing North Medical Health Economic Research Center, Beijing 100021, China
Abstract：OBJECTIVE To investigate the current situation of hospital pharmacists participating in chronic disease management, and to objectively analyze the influencing factors, so as to provide guidance for the establishment of reasonable chronic disease management team and development direction of pharmacists.METHODS A questionnaire was designed for hospital pharmacists at all levels nationwide. The questionnaire was divided into three parts, including basic information, development of pharmaceutical care for chronic disease management, and factors affecting pharmacists' participation in chronic disease management. RESULTS A total of 400 questionnaires were sent out and 391 were collected with a recovery rate of 97.8%. There were 113 males and 278 females from 28 provinces in China, and the majority of the pharmacists were between 31-45 years old(51.7%, n=202). Among them, 234(59.6%) were from tier 3 hospitals, and most of them have bachelor's degree(49.4%, n=199) and master's degrees(34.0%, n=133). Two hundred and four pharmacists(52.2%) were involved in chronic disease management. Two hundrwed and eighty-six pharmacists(73.1%) worked in hospital with chronic disease management unit. The majority of pharmacists involved in chronic disease management were full-time(16.6%, n=65) and part-time(49.6%, n=194).Pharmacists participated in chronic disease management in a variety of ways, including face-to-face(dropping in follow-up)(n=307, 78.5%), telephone follow-up(n=247, 63.2%), text message or WeChat follow-up(n=186, 48.6%). Pharmacists can complete prescription review and dispensing(51.2%, n=200), adverse reaction monitoring and guidance(37.1%, n=145), medication consultation and guidance(31.2%, n=122), and medication compliance education(23.0%, n=90). The influencing factors of pharmacists' participation in chronic disease management included lack of pharmaceutical care resources for chronic disease management(77.5%, n=303), patients' lack of trust in pharmacists (67.3%, n=263), lack of standardized pharmaceutical care procedures for chronic disease management(61.9%, n=242), and pharmacists' service cost(56.0%, n=219). CONCLUSION The pharmacists' team has gradually started or joined the chronic disease management team, and they have a positive attitude to participate in such work. The breadth of participation needs to be further improved.Objective policy conditions also limit the play space of pharmacists(pharmacists charge). The government and hospitals need to strengthen professional training for pharmacists and improve policy support, so that pharmacists can better participate in chronic disease management in the future.
孙雪林, 钱东方, 张子轩, 胡欣, 金鹏飞. 我国医疗机构药师参与慢病管理的现状调查分析[J]. 中国药学杂志, 2022, 57(13): 1131-1136.
SUN Xue-lin, QIAN Dong-fang, ZHANG Zi-xuan, HU Xin, JIN Peng-fei. Investigation and Analysis on the Involvement of Hospital Pharmacists in Chronic Disease Management in China. Chinese Pharmaceutical Journal, 2022, 57(13): 1131-1136.
ANS. Report on nutrition and chronic diseases in China(2020)[J]. Acta Nut Sin(营养学报), 2020, 42(6):521.
[2]
ZHOU M, WANG H, ZENG X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017[J]. Lancet, 2019, 394(10204):1145-1158.
[3]
CUI L, XI X Y, YAO D N, et al. National survey on clinical pharmacy services of tertiary hospitals in China: part 3. status quo of clinical pharmacy service provisio[J]. Chin Pharm J(中国药学杂志), 2018, 53(10):837-842.
[4]
ZHAO N, ZHAO R, LIU L H. Analysis on the current situation and requirements of pharmaceutical services in public hospitals in China[J]. Clin Med J(临床药物治疗杂志), 2020, 11(18):78-81.
[5]
LI J, LI J T, YAO W M, et al. New pharmaceutical care mode——Joint outpatient management ofchronic diseases by physician and pharmacists[J]. Cent South Pharm(中南药学), 2020, 18(1):158-162.
[6]
ZHANG Y, ZHANG Q J. Strengthen the construction of licensed pharmacists to promote the ability and education of licensed pharmacists[J]. China Food Drug Adm Mag(中国食品药品监管), 2020,(8):82-93.
[7]
WU D W, SHI N N, HAN S, et al. Effect of clinical pharmacist-led chronic disease management on medication compliance of elderly patients with hypertension[J]. Clin Med J(临床药物治疗杂志), 2018, 16(09):75-77,85.
[8]
CHEN X M. Clinical study on chronic disease management of type 2 diabetes patients by clinical pharmacists[J]. Strait Pharm J(海峡药学), 2020, 32(10):164-166.
[9]
CHEN S Q, ZHAO X, ZHOU Y, et al. Discussion of pharmacists' involving in chronic disease management model of heartfailure and its pharmaceutical care[J]. Chin J Clin Pharmacol(中国临床药理学杂志), 2017, 33(14):1360-1362.
[10]
BORTHWICK M, BARTON G, BOURNE R S, et al. Critical care pharmacy workforce:UK deployment and characteristics in 2015[J]. Int J Pharm Pract, 2018, 26(4):325-333.
[11]
LU J, YANG L J, LI W Y, et al. General standards for pharmaceutical care in medical institutions[J]. J China Pharm(中国药房), 2019, 30(23):3169-3174,3179.
[12]
ZHANG X Y, WAN Q, TANG N J, et al. A national online survey of pharmacist-managed clinics in tertiary hospitals in China[J]. Chin Pharm J(中国药学杂志), 2021, 56(10):849-853.
[13]
ZHAO W M, YANG Y, TIAN K. Enlightenment of American MTM model to the construction of pharmaceutical service capability in primary medical institutions in China[J]. Chin J New Drug(中国新药杂志), 2019, 28(11):1292-1296.
[14]
ZHANG Y H, FU X, HE W. Internet technology promotes the transformation of chronic disease management service model[J]. Chronic Pathematology J(慢性病学杂志), 2019, 20(9):1324-1326, 1330.
2022, Vol. 57 
